Deutsche Bank analyst George Hill raised the firm’s price target on Hims & Hers to $48 from $43 and keeps a Hold rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims & Hers Reports Strong Growth Amid Challenges
- ‘Time to Exit,’ as Bank of America Loses Faith in Hims & Hers Health Stock (HIMS)
- Mixed options sentiment in Hims and Hers Health with shares down 8.75%
- Hold Rating for Hims & Hers Health Amid Mixed Results and Growth Investments
- Hims & Hers Health: Hold Rating Amid Mixed Financial Performance and Strategic Transition